About Torrent Pharmaceuticals Limited (TORNTPHARM)
Torrent Pharmaceuticals Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India. TORNTPHARM has been publicly traded since 2002, giving it 24+ years of trading history.
Torrent Pharmaceuticals Limited (TORNTPHARM) has been publicly traded since 2002, making it a 24-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Ahmedabad, India and employs approximately 17,059 people. With a market capitalization of $1.5 trillion, TORNTPHARM is one of the largest publicly traded companies.
TORNTPHARM trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $1.5 trillion. The company employs approximately 17,059 people worldwide.
Key Statistics
- Current Price
- ₹4,390.00
- Market Cap
- ₹1.49T
- 52-Week High
- ₹4,482.90
- 52-Week Low
- ₹3,038.40
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
TORNTPHARM Investment Performance
TORNTPHARM has gained 14.8% year-to-date in 2026. Over the past 5 years, a $1,000 investment in TORNTPHARM would have grown to $3,650, representing a 265.0% total return. Since its IPO in 2002, a $1,000 investment would now be worth $527,332.
₹1,000 Invested in Torrent Pharmaceuticals Limited (TORNTPHARM)
How much would ₹1,000 invested in TORNTPHARM be worth today?
What would ₹1,000 invested in TORNTPHARM 1 year ago be worth today?
A ₹1,000 investment in Torrent Pharmaceuticals Limited (TORNTPHARM) in 2025 would be worth ₹1,441 as of May 2026, representing a +44.1% total return.
What would ₹1,000 invested in TORNTPHARM 3 years ago be worth today?
A ₹1,000 investment in Torrent Pharmaceuticals Limited (TORNTPHARM) in 2023 would be worth ₹3,056 as of May 2026, representing a +205.7% total return.
What would ₹1,000 invested in TORNTPHARM 5 years ago be worth today?
A ₹1,000 investment in Torrent Pharmaceuticals Limited (TORNTPHARM) in 2021 would be worth ₹3,650 as of May 2026, representing a +265.0% total return.
What would ₹1,000 invested in TORNTPHARM 10 years ago be worth today?
A ₹1,000 investment in Torrent Pharmaceuticals Limited (TORNTPHARM) in 2016 would be worth ₹6,863 as of May 2026, representing a +586.3% total return.
What would ₹1,000 invested in TORNTPHARM at IPO be worth today?
A ₹1,000 investment in Torrent Pharmaceuticals Limited (TORNTPHARM) at IPO would be worth ₹527,332 as of May 2026, representing a +52633.2% total return.
Monthly Returns Heatmap
Over the past 23+ years (284 months), Torrent Pharmaceuticals Limited (TORNTPHARM) has averaged a monthly return of +2.60% with a median return of +2.30%. The stock had 174 positive months (61%) and 110 negative months (39%). The best month in TORNTPHARM's history was August 2003 with a +38.5% return, while the worst was January 2008 at -20.7%. Historically, July tends to be the strongest month (averaging +8.1%), and January the weakest (-1.6%).
TORNTPHARM's longest winning streak was 11 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2009 with a cumulative return of +117.3%, and the worst was 2008 at -26.4%.
Annual Returns
Over 24 years of trading history, Torrent Pharmaceuticals Limited (TORNTPHARM) has delivered an average annual return of +36.74% with a median return of +27.87%. The compound annual growth rate (CAGR) is +29.71%. The stock posted gains in 19 years (79%) and losses in 5 years (21%).
TORNTPHARM's best year was 2009 with a +193.84% gain, while the worst was 2008 at -30.32%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. TORNTPHARM achieved double-digit gains (10%+) in 16 years. It suffered double-digit losses in 1 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +14.81% | ₹3,823.78 | ₹4,390.00 |
| 2025 | +15.70% | ₹3,305.05 | ₹3,823.78 |
| 2024 | +47.26% | ₹2,244.32 | ₹3,305.05 |
| 2023 | +50.70% | ₹1,489.28 | ₹2,244.32 |
| 2022 | -3.73% | ₹1,546.96 | ₹1,489.28 |
| 2021 | +18.50% | ₹1,305.50 | ₹1,546.96 |
| 2020 | +54.06% | ₹847.41 | ₹1,305.50 |
| 2019 | +5.41% | ₹803.95 | ₹847.41 |
| 2018 | +26.09% | ₹637.60 | ₹803.95 |
| 2017 | +8.92% | ₹585.37 | ₹637.60 |
| 2016 | -6.77% | ₹627.91 | ₹585.37 |
| 2015 | +29.64% | ₹484.33 | ₹627.91 |
| 2014 | +143.37% | ₹199.01 | ₹484.33 |
| 2013 | +34.30% | ₹148.18 | ₹199.01 |
| 2012 | +36.17% | ₹108.82 | ₹148.18 |
| 2011 | -5.31% | ₹114.93 | ₹108.82 |
| 2010 | +48.31% | ₹77.49 | ₹114.93 |
| 2009 | +193.84% | ₹26.37 | ₹77.49 |
| 2008 | -30.32% | ₹37.85 | ₹26.37 |
| 2007 | -3.34% | ₹39.16 | ₹37.85 |
| 2006 | +1.69% | ₹38.51 | ₹39.16 |
| 2005 | +49.67% | ₹25.73 | ₹38.51 |
| 2004 | +45.76% | ₹17.65 | ₹25.73 |
| 2003 | +106.93% | ₹8.53 | ₹17.65 |
TORNTPHARM Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Torrent Pharmaceuticals Limited as an investment
Valuation
TORNTPHARM currently trades at a trailing P/E ratio of 65.4, which is considered high relative to the broader market. The forward P/E of 68.8 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 17.6. The price-to-sales ratio is 11.7.
Dividends
Torrent Pharmaceuticals Limited pays a dividend to shareholders with a current yield of 0.80%. This translates to $35.00 per share annually. The payout ratio of 48% indicates sustainable dividend coverage.
Risk & Volatility
TORNTPHARM has a beta of 0.16, indicating it is less volatile than the overall market. The stock's 52-week range is $3038.40 to $4482.90, and it currently trades near its 52-week high.
Analyst Ratings
Based on 28 analyst opinions, TORNTPHARM has a consensus "buy" rating. The average price target of $4487.96 suggests 2.2% upside from current levels.
Frequently Asked Questions: TORNTPHARM
What sector is TORNTPHARM in? ▼
TORNTPHARM operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has TORNTPHARM performed historically? ▼
Over 24 years of trading history, TORNTPHARM has posted gains in 19 years (79% of the time). The best year was 2009 with a +193.8% return. Past performance does not guarantee future results.
How can I invest in TORNTPHARM? ▼
You can invest in TORNTPHARM through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold TORNTPHARM.
Does TORNTPHARM pay dividends? ▼
Torrent Pharmaceuticals Limited pays a dividend to shareholders with a current yield of 0.80%. This translates to $35.00 per share annually. The payout ratio of 48% indicates sustainable dividend coverage.
What does Torrent Pharmaceuticals Limited do? ▼
Torrent Pharmaceuticals Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India.
What sector is TORNTPHARM in? ▼
TORNTPHARM operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did TORNTPHARM go public? ▼
Torrent Pharmaceuticals Limited went public in 2002, making it a 24-year-old public company as of 2026.
How much would $1,000 invested in TORNTPHARM 5 years ago be worth today? ▼
A $1,000 investment in TORNTPHARM five years ago would be worth approximately $3,650 today, representing a 265.0% return.
Does TORNTPHARM pay dividends? ▼
Yes, Torrent Pharmaceuticals Limited pays a dividend with a current yield of 0.80%, which is $35.0 per share annually.
What is TORNTPHARM's market cap? ▼
Torrent Pharmaceuticals Limited has a market capitalization of $1.5 trillion, classifying it as a mega-cap company.
What is TORNTPHARM's P/E ratio? ▼
TORNTPHARM has a trailing P/E ratio of 65.4 and a forward P/E of 68.8, which measures how much investors are paying per dollar of earnings.
Is TORNTPHARM a buy, hold, or sell? ▼
Based on 28 opinions, TORNTPHARM has a consensus "buy" rating. The average price target is $4487.96.
Last updated: 3/14/2026